Personalized Medicine Not A Threat To Blockbuster Model - Lilly President Lechleiter

Pharma has rarely pursued one-size-fits-all strategies, instead segmenting disease categories or patient groups, an effort personalized medicine can only render more relevant and meaningful, exec says.